As unaffected carriers have never suffered from HNPCC-related symptoms, the MLH1 mRNA level is almost 2 times higher than the mutation carriers affected with Lynch syndrome. This evidence concerns the gene MLH1 and hereditary nonpolyposis colon cancer.